Barbara Green, RPh, MS

Barbara Green is Head of Global Upstream Research, Skin Health & Beauty, Kenvue where she is responsible for global scientific strategy and technology innovation to enable a compelling product and science pipeline for the company’s skin health and hair brands including Neutrogena®, Aveeno® Dr.CI:Labo® and OGX®. She is responsible to build internal and external research capabilities ensuring leading-edge, differentiated and ownable ingredient/technology claims and publishable, robust science. Barbara joined Kenvue after being acquired into Johnson & Johnson as part of the NeoStrata Company acquisition in 2016 where she led R&D and the development of the company’s patented skincare technology including alpha-hydroxy acids (AHAs, e.g., glycolic acid) and polyhydroxy acids (PHAs). She has a long history of developing scientifically-rigorous and novel products and science, and sharing externally through publications, book chapters and presentations. She is a graduate of Rutgers University, College of Pharmacy and earned a Master of Science degree in Pharmaceutical Chemistry. She is a registered pharmacist in the state of New Jersey and maintains an industrial advisory position with the Rutgers University Professional Science Master’s Program.